{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:01:28Z","timestamp":1792634488469,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.contraception.2023.109978","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T20:21:37Z","timestamp":1676838097000},"page":"109978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A commentary on progestin-only pills and the \u201cthree-hour window\u201d guidelines: Timing of ingestion and mechanisms of action"],"prefix":"10.1016","volume":"122","author":[{"given":"Alexandra","family":"Wollum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Teal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2023.109978_bib1","unstructured":"American College of Obstetricians and Gynecologists. Progestin-only hormonal birth control: pill and injection [Internet]. frequently asked questions: contraception; 2018. \u3008https:\/\/www.acog.org\/Patients\/FAQs\/Progestin-Only-Hormonal-Birth-Control-Pill-and-Injection?IsMobileSet=false#take\u3009 (cited September 17, 2019)."},{"key":"10.1016\/j.contraception.2023.109978_bib2","unstructured":"Centers for Disease Control and Prevention. US selected practice recommendations for contraceptive use [Internet]. 2019. \u3008https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/spr\/progestin.html\u3009 (cited September 17, 2019)."},{"key":"10.1016\/j.contraception.2023.109978_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2017.07.168","article-title":"Cervical mucus and contraception: what we know and what we don\u2019t","volume":"96","author":"Han","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib5","first-page":"167","article-title":"The pre-coital use of mini-dosage progestagens","volume":"Supplement 5","author":"Cox","year":"1968","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.contraception.2023.109978_bib6","unstructured":"United Nations. Consolidated list of products whose consumption and\/or sale have been banned, withdrawn, severely restricted or not approved by governments; 1983."},{"key":"10.1016\/j.contraception.2023.109978_bib7","doi-asserted-by":"crossref","first-page":"34628","DOI":"10.18632\/oncotarget.26015","article-title":"The clinical relevance of progestogens in hormonal contraception: present status and future developments","volume":"9","author":"Regidor","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.contraception.2023.109978_bib8","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Hormonal contraceptives, progestogens only [Internet]. Hormonal contraception and post-menopausal hormonal therapy. International Agency for Research on Cancer; 1999. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK396196\/\u3009 (cited September 30, 2022)."},{"key":"10.1016\/j.contraception.2023.109978_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17512433.2020.1821649","article-title":"Effects of progestin-only contraceptives on the endometrium","volume":"13","author":"Bastianelli","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.contraception.2023.109978_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4161\/cib.7502","article-title":"Communication between female tract and sperm","volume":"2","author":"Lefi\u00e8vre","year":"2009","journal-title":"Commun Integr Biol"},{"key":"10.1016\/j.contraception.2023.109978_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.contraception.2022.03.016","article-title":"Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception","volume":"112","author":"Han","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1089\/jwh.2020.8706","article-title":"A randomized study evaluating the effect of evidence-based information on clinician attitudes about moving oral contraceptives over the counter","volume":"30","author":"Wollum","year":"2021","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.contraception.2023.109978_bib14","article-title":"Progestin-only pills for contraception","volume":"11","author":"Grimes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2023.109978_bib15","article-title":"Effectiveness and efficacy rates of progestin-only pills: a comprehensive literature review","volume":"119","author":"Zuniga","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.contraception.2012.05.003","article-title":"Progestin-only contraceptive pill use among women in the United States","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.contraception.2015.12.007","article-title":"Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake","volume":"93","author":"Duijkers","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2004.07.016","article-title":"Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake","volume":"71","author":"Korver","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.contraception.2014.08.009","article-title":"Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy","volume":"91","author":"DuBois","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0002-9378(76)90689-X","article-title":"Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration","volume":"126","author":"Mills","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.109978_bib21","first-page":"308","article-title":"Further study of d-norgestrel for fertility control","volume":"46","author":"Roland","year":"1975","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.109978_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e3182a9b3f1","article-title":"Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women","volume":"65","author":"Atrio","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2023.109978_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s40262-021-00989-0","article-title":"Pharmacokinetic and pharmacodynamic profiles of ethinylestradiol\/norgestimate combination or norethindrone upon coadministration with elagolix 150 mg once daily in healthy premenopausal women","volume":"60","author":"Feldman","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2023.109978_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(01)01824-6","article-title":"Ovarian function during and after treatment with the new progestagen Org 30659","volume":"76","author":"Obruca","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2023.109978_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.109978_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0091270006289973","article-title":"Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function","volume":"46","author":"Sch\u00fcrmann","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2023.109978_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/13625187.2012.677076","article-title":"Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women","volume":"17","author":"Blode","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.109978_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.09.002","article-title":"The effect of deliberate non-adherence to a norgestrel progestin-only pill: a randomized, crossover study","volume":"117","author":"Glasier","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109978_bib29","first-page":"585","article-title":"Contraceptive mechanism of microdose norethindrone","volume":"41","author":"Moghissi","year":"1973","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.109978_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0015-0282(16)37083-2","article-title":"Effect of continuous administration of small doses of chlormadinone acetate on the cervical mucus and postcoital test","volume":"20","author":"Gibor","year":"1969","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2023.109978_bib31","series-title":"StatPearls","article-title":"Half life","author":"Hallare","year":"2022"},{"key":"10.1016\/j.contraception.2023.109978_bib32","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1021\/acs.jmedchem.7b00969","article-title":"Relevance of half-life in drug design","volume":"61","author":"Smith","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.contraception.2023.109978_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13669-020-00284-y","article-title":"Pharmacokinetics of hormonal contraception in individuals with obesity: a review","volume":"9","author":"Ramanadhan","year":"2020","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.contraception.2023.109978_bib34","unstructured":"Medicines and Healthcare products Regulatory Agency. First progestogen-only contraceptive pills to be available to purchase from pharmacies [Internet]. GOV.UK; 2021. \u3008https:\/\/www.gov.uk\/government\/news\/first-progesterone-only-contraceptive-pills-to-be-available-to-purchase-from-pharmacies\u3009 (cited March 3, 2022)."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:22:23Z","timestamp":1757881343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782423000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"alternative-id":["S0010782423000392"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.109978","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A commentary on progestin-only pills and the \u201cthree-hour window\u201d guidelines: Timing of ingestion and mechanisms of action","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.109978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109978"}}